Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet BRIVARACETAM ACCORD 25mg film-coated tablets
- Product code:
- W71428001
- Quantity:
- 14
- Indicated for:
- epilepsy
- Route of administration:
- oral
- Substance:
- brivaracetam (antiepileptic)
- ATC
- N03AX23 — Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Suicidal ideation / mental changes
Seek medical help if suicidal thoughts or major behavior changes occur.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Brivaracetam is a medication used for the treatment of epilepsy, specifically focal seizures with or without secondary generalization, in patients aged 4 years and older. It is an antiepileptic drug that works by binding to the synaptic vesicle protein SV2A, reducing neuronal excitability.
The medication is administered orally or intravenously, as directed by a doctor. The dosage is adjusted based on the patient's age, weight, and response to treatment.
Common side effects include drowsiness, dizziness, fatigue, and irritability. In rare cases, more severe adverse effects such as depression or suicidal thoughts may occur, requiring close monitoring of patients.
Brivaracetam is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
The medication is administered orally or intravenously, as directed by a doctor. The dosage is adjusted based on the patient's age, weight, and response to treatment.
Common side effects include drowsiness, dizziness, fatigue, and irritability. In rare cases, more severe adverse effects such as depression or suicidal thoughts may occur, requiring close monitoring of patients.
Brivaracetam is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
General data about BRIVARACETAM ACCORD 25mg
- Substance:
- brivaracetam
- Date of latest medicines list:
- 01-11-2025
- Product code:
- W71428001
- Concentration:
- 25mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 14
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for brivaracetam
Concentrations available for brivaracetam
- 100mg
- 10mg
- 10mg/ml
- 25mg
- 50mg
- 75mg